The National Agency for Food and Drug Administration and Control (NAFDAC) has dismissed viral social media reports alleging that Amoxicillin, a commonly prescribed antibiotic, has been secretly banned in Nigeria.
In a statement released on Monday via its official X account, the agency described the claims as false and misleading, clarifying that no nationwide prohibition exists.
NAFDAC explained that while it regularly issues safety alerts, recalls, and regulatory actions against specific substandard or falsified batches of medicines, these measures do not amount to a blanket ban.
“NAFDAC has not banned Amoxicillin in Nigeria, either secretly or openly. As a responsible regulatory authority, the Agency publicly notifies Nigerians of any regulatory actions through official channels,” the statement read.
The agency cited recent targeted alerts, including:
- August 2025: Recall of Amoxivue (Amoxicillin) 500mg capsules due to low active ingredient content.
- October 2025: Alerts on defective batches of Astamocil and Astamentin suspensions.
- October 2025: Notification on substandard batches of Annmox and Jawamox suspensions.
NAFDAC stressed that these actions were product-specific and did not represent a ban on Amoxicillin as a drug category.
The agency urged healthcare professionals, patients, and the public to disregard misinformation and rely solely on official updates issued through its verified communication channels to avoid unnecessary panic.
 has dismissed viral social media reports){kind=link}